Frontiers in medicine · 2025
Reduction of surgical-site infections and improvement of scar parameters with a uniform fractional ultra-pulse CO₂ laser protocol in cosmetic surgery: a five-center retrospective cohort.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xu Qinghua, Li Haoran, Zhao Juhui, He Xiao, Zhao Liliang, Zhang Xiaofeng
Аннотация
BACKGROUND: Postoperative infections and suboptimal scar outcomes remain persistent challenges in cosmetic surgery, impairing patient satisfaction and quality of life. This study evaluates whether a standardized fractional ultra-pulse CO₂ laser regimen can mitigate these complications.
METHODS: A multicenter retrospective cohort enrolled 562 adults undergoing elective rhinoplasty, liposuction, breast augmentation, facelift, abdominoplasty, or Botox. Laser eligibility (incision >3 cm, Fitzpatrick I-IV, no collagen-vascular disorder) was determined by an EMR-embedded checklist; 324 patients received a uniform three-stage laser protocol (pre-incision, immediate post-closure, day 10). All patients followed a five-day antibiotic regimen (oral cefalexin + topical mupirocin). Baseline covariates were balanced via IPTW. SSIs were microbiologically confirmed (aerobic, anaerobic, fungal, mycobacterial cultures with MALDI-TOF). Comparative analyses used Welch's t-test and Fisher's exact test; infection-free survival was assessed by Kaplan-Meier curves, and IPTW-adjusted Cox models quantified laser effects on SSI risk.
RESULTS: Of 562 patients, 324 (58%) received laser therapy. Baseline demographics and comorbidities were balanced across groups (all p > 0.05). Laser-treated patients had faster healing (13.8 ± 5.7 vs. 17.0 ± 3.2 days; p < 0.001), lower CRP (11.3 ± 7.4 vs. 14.9 ± 4.4 mg/L; p < 0.001), thinner scars (2.44 ± 1.39 vs. 3.14 ± 0.78 mm; p < 0.001), and greater elasticity (0.85 ± 0.03 vs. 0.65 ± 0.03 AU; p < 0.001). Pigmentation, vascularity, and collagen III/I ratios were all significantly improved (p < 0.001). SSIs were reduced (15% vs. 59%; p < 0.001), as were keloids (1.9% vs. 11%; p < 0.001). Satisfaction, quality-of-life scores, and return to activity favored the laser group (all p < 0.001). Kaplan-Meier curves confirmed superior 30-day infection-free survival (log-rank p < 0.001); IPTW-adjusted Cox regression showed a 72% reduced infection hazard (HR = 0.28; 95% CI: 0.19-0.41; p < 0.001).
CONCLUSION: Standardized fractional ultra-pulse CO₂ laser therapy reduces SSIs, improves scar outcomes, and enhances patient satisfaction in cosmetic surgery. These findings support wider adoption of laser protocols, warranting further prospective, pathogen-specific research.
METHODS: A multicenter retrospective cohort enrolled 562 adults undergoing elective rhinoplasty, liposuction, breast augmentation, facelift, abdominoplasty, or Botox. Laser eligibility (incision >3 cm, Fitzpatrick I-IV, no collagen-vascular disorder) was determined by an EMR-embedded checklist; 324 patients received a uniform three-stage laser protocol (pre-incision, immediate post-closure, day 10). All patients followed a five-day antibiotic regimen (oral cefalexin + topical mupirocin). Baseline covariates were balanced via IPTW. SSIs were microbiologically confirmed (aerobic, anaerobic, fungal, mycobacterial cultures with MALDI-TOF). Comparative analyses used Welch's t-test and Fisher's exact test; infection-free survival was assessed by Kaplan-Meier curves, and IPTW-adjusted Cox models quantified laser effects on SSI risk.
RESULTS: Of 562 patients, 324 (58%) received laser therapy. Baseline demographics and comorbidities were balanced across groups (all p > 0.05). Laser-treated patients had faster healing (13.8 ± 5.7 vs. 17.0 ± 3.2 days; p < 0.001), lower CRP (11.3 ± 7.4 vs. 14.9 ± 4.4 mg/L; p < 0.001), thinner scars (2.44 ± 1.39 vs. 3.14 ± 0.78 mm; p < 0.001), and greater elasticity (0.85 ± 0.03 vs. 0.65 ± 0.03 AU; p < 0.001). Pigmentation, vascularity, and collagen III/I ratios were all significantly improved (p < 0.001). SSIs were reduced (15% vs. 59%; p < 0.001), as were keloids (1.9% vs. 11%; p < 0.001). Satisfaction, quality-of-life scores, and return to activity favored the laser group (all p < 0.001). Kaplan-Meier curves confirmed superior 30-day infection-free survival (log-rank p < 0.001); IPTW-adjusted Cox regression showed a 72% reduced infection hazard (HR = 0.28; 95% CI: 0.19-0.41; p < 0.001).
CONCLUSION: Standardized fractional ultra-pulse CO₂ laser therapy reduces SSIs, improves scar outcomes, and enhances patient satisfaction in cosmetic surgery. These findings support wider adoption of laser protocols, warranting further prospective, pathogen-specific research.